Trials / Completed
CompletedNCT05955612
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
Use of Procalcitonin Point-of-care Test to Guide De-escalation of Empiric Antibiotic Therapy in Adult Patients With Sepsis in a Tertiary Hospital in Bangladesh (PROCALBAN): a Phase 3 Randomised, Controlled, Open-label Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 532 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Trial design: Randomised controlled, two-arm, parallel, clinical trial to assess the efficacy and safety of sequential daily procalcitonin assessments to guide de-escalation of empirical antibiotic therapy in adult patients with sepsis. Trial settings Trial site is Chattogram Medical College Hospital (CMCH), Bangladesh. CMCH is tertiary care hospital with undergraduate and postgraduate teaching facilities. This tertiary hospital receives referrals from urban and rural areas of southern Bangladesh and has basic facilities for intensive care and haemodialysis. Trial Participants: Male or female hospitalised patients, 16-65 years of age, with confirmed or suspected sepsis Patients (Total 532) will be 1:1 randomised to either: * Intervention arm: daily measurement of serum procalcitonin concentrations to guide de-escalation of antibiotics (Intervention arm: 266), or * Control arm: standard of practice to guide de-escalation of antibiotics without procalcitonin assessments (Control arm: 266). Patients will be followed-up until ICU discharge and/or hospital discharge with an additional follow-up at 28 days after discharge. Funder: Wellcome Trust of Great Britain Grant reference number from Wellcome Trust: 220211/A/20/Z
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Procalcitonin measurement | Daily measurement of serum procalcitonin concentrations to guide de-escalation of antibiotics |
Timeline
- Start date
- 2023-07-26
- Primary completion
- 2024-06-20
- Completion
- 2024-07-30
- First posted
- 2023-07-21
- Last updated
- 2024-11-26
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT05955612. Inclusion in this directory is not an endorsement.